![Anna Protopapas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anna Protopapas
Chairman at
NUVALENT, INC.
Net worth: 275 865 $ as of 31/05/2026
Profile
Anna Protopapas is the Independent Chairman at Nuvalent, Inc. since 2022.
Former roles include President & Chief Executive Officer at Millennium Pharmaceuticals, Inc. from 2013 to 2014; Independent Director at ARIAD Pharmaceuticals, Inc. from 2015 to 2017; Director at Ensemble Therapeutics Corp.; Independent Director at Dicerna Pharmaceuticals, Inc. from 2019 to 2021; Director at Mersana Therapeutics, Inc. from 2023 to 2026; Director at Bioverativ, Inc. from 2017 to 2018; Executive VP-Global Business Development at Takeda Pharmaceutical Co., Ltd. from 2010 to 2014; and Head-Global Business Development at Takeda Pharmaceuticals International, Inc. from 2010 to 2014.
Education includes graduate studies at Massachusetts Institute of Technology, undergraduate studies at Princeton University, and an MBA from Stanford Graduate School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2026 | 2,499 ( 0% ) | 275 865 $ | 31/05/2026 | |
| 06/01/2026 | 0 ( -.--% ) | - $ | 31/12/2025 |
Anna Protopapas active positions
| Companies | Position | Start |
|---|---|---|
| NUVALENT, INC. | Chairman | 30/03/2022 |
Former positions of Anna Protopapas
| Companies | Position | End |
|---|---|---|
| MERSANA THERAPEUTICS | Chief Executive Officer | 10/09/2023 |
| DICERNA PHARMACEUTICALS, INC. | Director/Board Member | 03/06/2021 |
| BIOVERATIV INC | Director/Board Member | 08/03/2018 |
| ARIAD PHARMACEUTICALS, INC. | Director/Board Member | 16/01/2017 |
Takeda Pharmaceuticals International, Inc.
 Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting for pharmaceutical businesses | Corporate Officer/Principal | 01/10/2014 |
Training of Anna Protopapas
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
83
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Ensemble Therapeutics Corp.
 Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Develops novel classes of therapeutics and bioassays for research and diagnostics | Process Industries |
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting for pharmaceutical businesses | Commercial Services |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
Nuvalent, Inc.
 Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
- Stock Market
- Insiders
- Anna Protopapas
